Return on Tangible Equity: The amount of net income returned as a percentage of shareholders equity, after subtracting intangible assets, goodwill and preferred equity. Calculated as: Income from Continuing Operations / Tangible Shareholders Equity
Sonoma Pharmaceuticals, Inc. (SNOA) had Return on Tangible Equity of -78.78% for the most recently reported fiscal year, ending 2024-03-31.
| Income Statement Financials | |
$12.73M |
|
$-4.83M |
|
$7.99M |
|
$4.75M |
|
$17.44M |
|
$-4.70M |
|
$-0.33M |
|
$-5.03M |
|
$-5.03M |
|
$-4.83M |
|
$-4.83M |
|
$-4.83M |
|
$-4.83M |
|
$-4.70M |
|
$-4.53M |
|
0.45M |
|
0.45M |
|
$-10.60 |
|
$-10.60 |
|
| Balance Sheet Financials | |
$12.55M |
|
$0.36M |
|
$2.19M |
|
$14.74M |
|
$3.72M |
|
-- |
|
$4.88M |
|
$8.60M |
|
$6.14M |
|
$6.14M |
|
$6.14M |
|
0.78M |
|
| Cash Flow Statement Financials | |
$-2.40M |
|
$-0.00M |
|
$1.68M |
|
$3.82M |
|
$3.13M |
|
$-0.69M |
|
$0.52M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
3.37 |
|
-- |
|
-- |
|
-- |
|
0.05 |
|
37.26% |
|
-36.91% |
|
-36.91% |
|
-35.53% |
|
-39.51% |
|
-37.97% |
|
$-2.42M |
|
-- |
|
-- |
|
-- |
|
0.86 |
|
2.94 |
|
4.39 |
|
83.06 |
|
-78.78% |
|
|
Return on Tangible Equity |
-78.78% |
-32.80% |
|
-78.78% |
|
$7.86 |
|
$-5.31 |
|
$-5.28 |
|